Country: Велика Британија
Језик: Енглески
Извор: MHRA (Medicines & Healthcare Products Regulatory Agency)
Ferrous fumarate
Advanz Pharma
B03AA02
Ferrous fumarate
210mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 09010101; GTIN: 5060010019664
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT FERROUS FUMARATE 210MG TABLETS Ferrous fumarate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. -Keep this leaflet. You may need to read it again. -If you have any further questions, ask your doctor or pharmacist. -This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. -If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. The name of your medicine is Ferrous Fumarate 210mg Tablets. It will be referred to as Ferrous Fumarate Tablets for ease hereafter. WHAT IS IN THIS LEAFLET: 1. What Ferrous Fumarate Tablets are and what they are used for 2. What you need to know before you take Ferrous Fumarate Tablets 3. How to take Ferrous Fumarate Tablets 4. Possible side effects 5. How to store Ferrous Fumarate Tablets 6. Contents of the pack and other information 1. WHAT FERROUS FUMARATE TABLETS ARE AND WHAT THEY ARE USED FOR Ferrous Fumarate Tablets contain a form of iron called ferrous fumarate. Iron is usually found in foods and is necessary for the normal development of red blood cells. A lack of iron affects the development of the red blood cells and causes a reduction in the number of red blood cells found in the body (iron deficiency anaemia). Ferrous Fumarate Tablets are used to prevent or treat iron deficiency anaemia. The prevention of iron deficiency during pregnancy usually requires a combination of iron and folic acid. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE FERROUS FUMARATE TABLETS DO NOT TAKE FERROUS FUMARATE TABLETS IF: • You are allergic to ferrous fumarate or any of the other ingredients of this medicine (listed in section 6) • You have noticed blood in your urine • You suffer from any form of anaemia, other than iron deficiency anaemia, or from any other condition where your body’s iron is affected (y Прочитајте комплетан документ
OBJECT 1 FERROUS FUMARATE 210MG TABLETS Summary of Product Characteristics Updated 23-May-2022 | ADVANZ Pharma • 1. Name of the medicinal product • 2. Qualitative and quantitative composition • 3. Pharmaceutical form • 4. Clinical particulars • 4.1 Therapeutic indications • 4.2 Posology and method of administration • 4.3 Contraindications • 4.4 Special warnings and precautions for use • 4.5 Interaction with other medicinal products and other forms of interaction • 4.6 Fertility, pregnancy and lactation • 4.7 Effects on ability to drive and use machines • 4.8 Undesirable effects • 4.9 Overdose • 5. Pharmacological properties • 5.1 Pharmacodynamic properties • 5.2 Pharmacokinetic properties • 5.3 Preclinical safety data • 6. Pharmaceutical particulars • 6.1 List of excipients • 6.2 Incompatibilities • 6.3 Shelf life • 6.4 Special precautions for storage • 6.5 Nature and contents of container • 6.6 Special precautions for disposal and other handling • 7. Marketing authorisation holder • 8. Marketing authorisation number(s) • 9. Date of first authorisation/renewal of the authorisation • 10. Date of revision of the text 1. Name of the medicinal product Fersamal 210mg tablets Ferrous fumarate 210mg Tablets 2. Qualitative and quantitative composition Each tablet contains 210mg ferrous fumarate BP For the full list of excipients, see section 6.1. 3. Pharmaceutical form Tablet Light brown biconvex tablets. 4. Clinical particulars 4.1 Therapeutic indications Prophylaxis and treatment of iron deficiency states. For prophylaxis during pregnancy, a combination of iron and folic acid is usually recommended. 4.2 Posology and method of administration Posology ADULTS AND THE ELDERLY: Iron deficiency anaemia - 1 tablet two to three times a day; prophylaxis - 1 tablet once or twice a day. _Paediatric population_: Not recommended, suggest use of Fersamal syrup. The tablets are easy to swallow but may also be crushed or chewed being almost tasteless. Rationale: Taking into accou Прочитајте комплетан документ